Price $0.55 |
Market Cap
8.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.33
|
P/S
0.18
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-7.5K
|
FCF
-0.5
|
|
Op. Margin
-34.40%
|
Net Margin
-35.10%
|
ROE
-52.30%
|
ROI
-6.30%
|
|
ROA
-30.40%
|
EPS Growth
-477.80%
|
Current Ratio
3.9
|
Debt/Equity
3.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chembio Diagnostics Inc (CEMI) | $0.36 | - | - | 7.5M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $0.42 | - | - | 14.9M | Strong Buy |
| Evofem Biosciences Inc (EVFM) | $0.05 | - | - | 6.3M | Strong Buy |
| Aveo Pharmaceuticals Inc (AVEO) | $15.00 | - | - | 519.4M | Strong Buy |
| Aveanna Healthcare Holdings In (AVAH) | $1.20 | - | - | 125.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
